ClinicalTrials.gg
RecruitingNCT07779070Updated Sep 1, 2026

Supervised vs. Home Schroth Exercise in AIS

An interventional study of Supervised Schroth Exercise and Home-Based Schroth Exercise in Adolescent Idiopathic Scoliosis (AIS), sponsored by Bitlis Eren University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Bitlis Eren University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 132 studies in Scoliosis with a site in Turkey — 32 open to participants now, 35 under way, none of them phase 3. Scoliosis · Turkey.

Planned enrollment
6th of 78
62 · median 32
Started
2026
with 15 others
No phase
77 of 132
15 open now
Primary completion
2027-08
later than 31 of 34 live
Registered
129th of 132
by date

Among the 132 studies in Scoliosis with a site in Turkey, this one is the 6th largest by planned enrollment of the 78 interventional ones that give a count, is one of 16 that started in 2026, is one of 77 with no phase, reaches primary completion later than 31 of the 34 other live ones, and was the 129th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.

Browse Scoliosis studies →

Open to participants now

32 of the 132 studies in Scoliosis with a site in Turkey are open now. Recruiting first, the newest first:

26 more — sign in →

All 32 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Scoliosis with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to compare the effectiveness of supervised Schroth exercises versus a home-based exercise program in adolescents with Adolescent Idiopathic Scoliosis (AIS).

Read the detailed description

Adolescent Idiopathic Scoliosis (AIS) is a three-dimensional spinal deformity that develops in children aged 10-18, affecting approximately 0.47% to 12% of this population. If left untreated, curves between 10° and 45° may progress, leading to pain, breathing difficulties, postural problems, and reduced quality of life. Although bracing and surgery are traditional options, they have limitations. Physiotherapeutic scoliosis-specific exercises (PSSE), particularly the Schroth method, are increasingly recommended as a first-line conservative treatment.

03

Conditions studied

  • Adolescent Idiopathic Scoliosis (AIS)

Browse trials for

Keywords

  • Adolescent Idiopathic Scoliosis
  • Schroth Exercise
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Adolescent Idiopathic Scoliosis (idiopathic etiology)
  • Age between 10 and 18 years
  • Cobb angle between 10° and 45°
  • Able to participate in a 5-day/week exercise program (supervised or home-based)
  • Patient and parent/guardian provide written
  • Sufficient cooperation to comply with the study protocol and complete assessments

Exclusion criteria

Exclusion Criteria:

  • Non-idiopathic scoliosis (neuromuscular, congenital, functional, etc.)
  • Prior or planned spinal surgery
  • Neurological, rheumatological, metabolic, or cardiopulmonary disease that would interfere with participation
  • Brace treatment within the last 6 months or planned during the study
  • Regular scoliosis-specific exercise (more than 2 days/week) within the last 6 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Supervised Schroth Exercise Group (SSEG)

    Participants in this group will receive the exercise program under direct, one-on-one supervision by a physiotherapist. This is a purely physical exercise intervention. No drugs or devices are used as part of the intervention. Only the Schroth exercise program is administered.

    Other: Supervised Schroth Exercise

  • Active comparator
    Home Exercise Program Group (HEPG)

    Participants in this group will be provided with an individualized home exercise program that matches the supervised group in terms of principles, content, and duration. This is a purely physical exercise intervention. No drugs or devices are used as part of the intervention. Only the Schroth exercise program is administered.

    Other: Home-Based Schroth Exercise

Interventions

  • OtherSupervised Schroth Exercise

    60-minute Schroth exercise sessions, 5 days/week for 12 weeks, delivered under one-on-one physiotherapist supervision. Includes 3D auto-correction, rotational breathing, postural stabilization, and curve-specific exercises (shoulder counter-pull, muscle cylinder, side-lying, sailing, prominent hip, Schroth walking)

  • OtherHome-Based Schroth Exercise

    Same 60-minute Schroth exercise program, 5 days/week for 12 weeks, performed at home without direct physiotherapist supervision. Participants receive initial instruction and an individualized exercise booklet.

06

What researchers measure

Primary outcomes

  1. Change in Cobb Angle

    Change in the primary curve Cobb angle measured on standing posteroanterior full-spine radiographs, assessed at baseline and 3 months post-intervention.

    Time frame: Baseline and 3 months post-intervention

Secondary outcomes

  1. Change in Trunk Rotation Angle (ATR)

    Change in angle of trunk rotation measured using a scoliometer during the Adam's Forward Bend Test.

    Time frame: Baseline and 12 weeks

  2. Change in Thoracic Kyphosis

    Change in thoracic kyphosis angle measured using an inclinometer at T1-T2 and T12-L1 levels.

    Time frame: Baseline and 12 weeks

  3. Change in Lumbar Lordosis

    Change in lumbar lordosis angle measured using an inclinometer at T12-L1 and S2-S3 levels.

    Time frame: Baseline and 12 weeks

  4. Respiratory Function assessed by Spirometry (FVC, FEV1, FEV1/FVC, PEF, FEF25-75%)

    Respiratory function will be assessed using a spirometry device. The following parameters will be recorded and analyzed: Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), the FEV1/FVC ratio, Peak Expiratory Flow (PEF), and Forced Expiratory Flow at 25-75% of FVC (FEF25-75%).

    Time frame: Baseline and 12 weeks

  5. Change in Pain Level

    Change in musculoskeletal pain/discomfort assessed using the Turkish-validated Cornell Musculoskeletal Discomfort Questionnaire (T-CMDQ) \[19\]. The questionnaire evaluates discomfort in 18 body regions over the past week across three dimensions: frequency, severity, and functional impact on daily activities. A risk score is calculated for each body region by multiplying these three parameters. For bilaterally assessed regions, the higher of the two side-specific scores is used in the analysis. Higher scores indicate worse outcomes.

    Time frame: Baseline and 12 weeks

  6. Change in Quality of Life

    Change in health-related quality of life assessed using the Turkish-validated Scoliosis Research Society-22 (SRS-22) questionnaire. The questionnaire consists of five domains: function, pain, self-image, mental health, and treatment satisfaction. Each item is scored from 1 (worst) to 5 (best); domain and total scores range from 1 to 5. Higher scores indicate better outcomes. The treatment satisfaction domain will be assessed only at 12 weeks; other domains assessed at both baseline and 12 weeks.

    Time frame: Baseline and 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Silivri Devlet Hastanesi, Fizik Tedavi Ünitesi
    Siliviri, Istanbul 34570, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Aug 2027, 12 months after the start.

Of 223 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 12 months is below that.

Counting every sponsor, half of 233 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2026
First posted
Aug 21, 2026
StartActual
Aug 31, 2026
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Sep 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07779070
Lead sponsor
Bitlis Eren University
Responsible party
Mesut Arslan (Assistant Professor, Bitlis Eren University) — Principal investigator
First posted
Aug 21, 2026
Start date
Aug 31, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Sep 1, 2026

Study contacts

Mesut Arslan, PhD
Contact
fzt.mesutarslan@gmail.com
+90 553 674 5226

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion